Wilkins A - Search Results

1

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis.

Redondo J, Sarkar P, Kemp K, Heesom KJ, Wilkins A, Scolding NJ, Rice CM. Redondo J, et al. Among authors: wilkins a. Stem Cells Transl Med. 2018 Oct;7(10):748-758. doi: 10.1002/sctm.18-0045. Epub 2018 Jul 31. Stem Cells Transl Med. 2018. PMID: 30063300 Free PMC article.

2

Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.

Mallam E, Kemp K, Wilkins A, Rice C, Scolding N. Mallam E, et al. Among authors: wilkins a. Mult Scler. 2010 Aug;16(8):909-18. doi: 10.1177/1352458510371959. Epub 2010 Jun 11. Mult Scler. 2010. PMID: 20542920

3

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Kemp K, et al. Among authors: wilkins a. Stem Cell Rev Rep. 2010 Dec;6(4):548-59. doi: 10.1007/s12015-010-9178-6. Stem Cell Rev Rep. 2010. PMID: 20683679

4

Changes in expression of the antioxidant enzyme SOD3 occur upon differentiation of human bone marrow-derived mesenchymal stem cells in vitro.

Nightingale H, Kemp K, Gray E, Hares K, Mallam E, Scolding N, Wilkins A. Nightingale H, et al. Among authors: wilkins a. Stem Cells Dev. 2012 Jul 20;21(11):2026-35. doi: 10.1089/scd.2011.0516. Epub 2012 Jan 26. Stem Cells Dev. 2012. PMID: 22132904

5

Primary progressive multiple sclerosis: progress and challenges.

Rice CM, Cottrell D, Wilkins A, Scolding NJ. Rice CM, et al. Among authors: wilkins a. J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1100-6. doi: 10.1136/jnnp-2012-304140. Epub 2013 Feb 16. J Neurol Neurosurg Psychiatry. 2013. PMID: 23418213 Review.

6

Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.

Rice CM, Kemp K, Wilkins A, Scolding NJ. Rice CM, et al. Among authors: wilkins a. Lancet. 2013 Oct 5;382(9899):1204-13. doi: 10.1016/S0140-6736(13)61810-3. Lancet. 2013. PMID: 24095194

7

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum.

Redondo J, Kemp K, Hares K, Rice C, Scolding N, Wilkins A. Redondo J, et al. Among authors: wilkins a. Brain Pathol. 2015 Nov;25(6):692-700. doi: 10.1111/bpa.12230. Epub 2014 Dec 31. Brain Pathol. 2015. PMID: 25411024 Free PMC article.

8

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro.

Redondo J, Sarkar P, Kemp K, Virgo PF, Pawade J, Norton A, Emery DC, Guttridge MG, Marks DI, Wilkins A, Scolding NJ, Rice CM. Redondo J, et al. Among authors: wilkins a. Mult Scler. 2018 Jun;24(7):919-931. doi: 10.1177/1352458517711276. Epub 2017 May 26. Mult Scler. 2018. PMID: 28548004 Free PMC article.

9

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis.

Sarkar P, Redondo J, Kemp K, Ginty M, Wilkins A, Scolding NJ, Rice CM. Sarkar P, et al. Among authors: wilkins a. Cytotherapy. 2018 Jan;20(1):21-28. doi: 10.1016/j.jcyt.2017.08.007. Epub 2017 Sep 13. Cytotherapy. 2018. PMID: 28917625 Free PMC article.

10

Advising patients seeking stem cell interventions for multiple sclerosis.

von Wunster B, Bailey S, Wilkins A, Marks DI, Scolding NJ, Rice CM. von Wunster B, et al. Among authors: wilkins a. Pract Neurol. 2018 Dec;18(6):472-476. doi: 10.1136/practneurol-2018-001956. Epub 2018 May 30. Pract Neurol. 2018. PMID: 29848512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

721 results

Search Page